-transparent.png){kind=logo}
From a review of the clinical charts of 198 depressed outpatients, information was extracted on common major treatment emergent side effects associated with phenelzine, tranylcypromine, and imipramine. These included hypertensive reactions, severe orthostatic hypotension, hypomania, significant weight gain, sexual dysfunction, and a residual category of multiple side effects which together culminated in drug discontinuation. In this report, frequency of their occurrence for each drug, level of severity, relation to dose and treatment duration, and physician response at the time the side effect was recorded are described. In addition, procedures found useful in the clinical management of these side effects are discussed.
J G Rabkin, and
F M Quitkin, and
P McGrath, and
W Harrison, and
E Tricamo
November 1964,
JAMA,
J G Rabkin, and
F M Quitkin, and
P McGrath, and
W Harrison, and
E Tricamo
February 1988,
Der Nervenarzt,
J G Rabkin, and
F M Quitkin, and
P McGrath, and
W Harrison, and
E Tricamo
March 1964,
British medical journal,
J G Rabkin, and
F M Quitkin, and
P McGrath, and
W Harrison, and
E Tricamo
March 1981,
Drugs,
J G Rabkin, and
F M Quitkin, and
P McGrath, and
W Harrison, and
E Tricamo
February 1960,
Diseases of the nervous system,
J G Rabkin, and
F M Quitkin, and
P McGrath, and
W Harrison, and
E Tricamo
August 1993,
Biological psychiatry,
J G Rabkin, and
F M Quitkin, and
P McGrath, and
W Harrison, and
E Tricamo
October 1981,
Annals of allergy,
J G Rabkin, and
F M Quitkin, and
P McGrath, and
W Harrison, and
E Tricamo
June 1990,
Canadian family physician Medecin de famille canadien,
J G Rabkin, and
F M Quitkin, and
P McGrath, and
W Harrison, and
E Tricamo
January 1980,
International journal of psychiatry in medicine,
J G Rabkin, and
F M Quitkin, and
P McGrath, and
W Harrison, and
E Tricamo
December 2007,
Journal of clinical psychopharmacology,
